Scinus wins PRIX GALIEN medtech innovation AWARD 2022
Scinus wins PRIX GALIEN medtech innovation AWARD. At the 28th presentation of the Prix Galien Nederland Awards 2022, the Prix Galien MedTech Innovation Award was presented for the 4th time. Scinus Cell Expansion - a Demcon Investment company - received the MedTech...
Advanced microcarrier for cultivation of iPSC’s.
Stem cells are promising for developing cell therapies, screening new medicines and modeling diseases. Induced pluripotent stem cells (iPSCs) are very useful for this purpose, but producing large quantities of these cells is a challenge. Stem cells are promising for...
Prometheus at KU Leuven, Belgium installs novel bioreactor from SCINUS Cell Expansion
Bringing automated, precision manufacture of complex 3d-tissue engineered implants a step closer to patients. Joint defects involving the surface cartilage and underlying bone are one of the major causes of osteoarthritis, the most common arthritic disease, affecting...
Developing an efficient cell therapy production platform
Developing an efficient cell therapy production platformBilthoven (NL), November 2020 Eurostars project Bioscale focuses on the SCINUS expansion system Developing an efficient cell therapy production platform Cell therapy (CT), using cultured human cells, is a...